Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDK.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JG.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JF.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.529 (Omicron)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.41.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.3.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.33 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.14.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.14.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1 (Omicron)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.17.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.99.2 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.39.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.58.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used